tar cancer

tar cancer的基本解释

-

[医] 煤焦油癌, 柏油癌

与tar cancer相关的网络例句 [注：此内容来源于网络，仅供参考]

Similarly yellow ribbons for bladder cancer, purple ribbon for pancreatic cancer, testicular cancer and thyroid cancer, brown or royal blue ribbons for colon cancer, golden, pink or light blue for childhood cancer, green ribbons for kidney cancer, pearl white ribbons for lung cancer, plain white ribbons for bone cancer, orange ribbons for blood cancer, burgundy ribbons for multiple cancer, gray ribbons for brain cancer, blue ribbons for prostate cancer and black ribbons for skin cancer.

同样的黄色丝带为膀胱癌，紫色的丝带胰腺癌，睾丸癌和甲状腺癌，棕色或皇家蓝丝带结肠癌，金，粉红色或淡蓝色的儿童癌症，绿丝带为肾癌，珍珠白丝带肺癌，纯白色的丝带为骨癌，橙色丝带为血癌，勃艮第带多个癌症，灰色丝带为脑癌，蓝丝带的前列腺癌和黑丝带的皮肤癌。

Targeting the biomass rice stalk,we use linestone as catalyst and cracking catalyse the tar which was pyrolysised from the target.We build the rice straw biomass gasification tar removal catalytic cracking process model by the least squares support vector machine model and optimize the model parameters through genetic algorithm.We also has gotten the best catalytic cracking temperature and gas residence time, making the highest rate of catalytic cracking tar.We made wood biomass as a target analysis so that we can thermally crack tar,and we can use genetic algorithms to optimize the model parameters that is based on the wood biomass gasification pyrolysis tar removal process model through the least-squares fitting method,then we got the best pyrolysis temperature and equivalence ratio,so that it is possible to make the tar content reach the minianum.Based on the least squares support vector machine model,we had established the model of the biomass sawdust Compression molding process and fit the Optimization Parameters objective function of the molding process .

以生物质稻秆为对象，采用石灰石作为催化剂对稻秆热解焦油进行催化裂解，由最小二乘支持向量机模型建立了生物质稻秆气化焦油催化裂解脱除过程的模型，并用遗传算法对模型参数进行了优化，得到了最佳的催化裂解温度和气相停留时间，使得焦油催化裂解率达到最高；以生物质木屑作为分析对象，对其进行热裂解脱焦，并依据最小二乘曲线拟合方法建立了生物质木屑气化焦油热裂解脱除过程的模型，用遗传算法对模型参数进行了优化，得到了最佳的热裂解温度和当量比，使得焦油含量达到最小。

The stable clones are further identified by RT-PCR and Western blot; 6 MTT assay is used to investigate the effect of ZNRD1 on the cell growth of cells (AGS, SGC7901, MKN28, NIH3T3, GES-1); 7 Soft agar assay is used to investigate the effect of ZNRD1 on the clonality of cells (AGS, MKN28); 8 Nude mice assay is used to investigate the effect of ZNRD1 on the cell growth of gastric cancer cells (AGS, MKN28); 9 Flow cytometry is used to investigate the effect of ZNRD1 on the cell cycle distribution of cells (AGS, MKN28, NIH3T3, GES-1); 10 Flow cytometry is used to investigate the effect of ZNRD1 on the cell apoptosis of cells (AGS, MKN28, NIH3T3); 11 MTT assay is used to investigate the effect of ZNRD1 on the drug sensitivity of cancer cells (SGC7901, SGC7901/VCR, HL-60, HL-60/VCR) in vitro; 12 SRCA is used to investigate the effect of ZNRD1 on the drug sensitivity of gastric cancer cells (SGC7901, SGC7901/VCR) in vivo; 13 Flow cytometry is used to investigate the effect of ZNRD1 on adriamycin accumulation of cancer cells (SGC7901, SGC7901/VCR, HL-60, HL-60/VCR); 14 Transmission electron microscope is used to investigate the effect of ZNRD1 on the sensitivity of SGC7901 cells towards drug-induced apoptosis; 15 Flow cytometry and DNA ladder assay are used to investigate the effect of ZNRD1 on the sensitivity of cells (SGC7901, SGC7901/VCR, HL-60/VCR) towards drug-induced apoptosis; 16 Microarray is used to investigate the profiling of ZNRD1-responsive genes in gastric cancer cells (AGS, MKN28, SGC7901, SGC7901/VCR); 17 RT-PCR and Western blot are used to identify the results of microarray; 18 Reporter gene assay is used to investigate the effect of ZNRD1 on the transcriptional activity of cyclin D1; 19 Reporter gene assay is used to investigate the effect of ZNRD1 on the transcriptional activity of MDR1; 20 Kinase assay is used to investigate the effect of ZNRD1 on the activity of cyclin E-CDK2 kinase; 21 The antisensenucleic acids of p21 is used to inhibit the expression of p21, and flow cytometry is used to investigate the effect of p21 on ZNRD1-induced cell cycle arrest in gastric cancer cells; 22 The antisensenucleic acids of p27 is used to inhibit the expression of p27, and flow cytometry is used to investigate the effect of p27 on ZNRD1-induced cell cycle arrest in gastric cancer cells; 23 Liposome is used to up-regulate the expression of Skp2, and flow cytometry is used to investigate the effect of Skp2 on ZNRD1-induced cell cycle arrest in gastric cancer cells; 24 Western blot is used to investigate the effect of ZNRD1 on the stability of Skp2 and p27 in gastric cancer cells; 25 MVD assay is used to investigate the effect of ZNRD1 on the angiopoietic activity of gastric cancer cells; 26 ELISA is used to investigate the effect of ZNRD1 on the expression of VEGF165 in gastric cancer cells; 27 The roles of DARPP-32 in MDR of gastric cancer cells are investigated using gene transfection, MTT assay, SRCA, flow cytometry and DNA ladder assay.

应用杂交瘤技术制备ZNRD1的首个单克隆抗体；2）利用RT-PCR、Western blot和免疫组化检测ZNRD1在胃癌组织、胃炎组织、正常胃上皮组织、胃癌细胞和正常胃组织上皮细胞中的表达；3）构建ZNRD1的小干扰RNA载体，并测序鉴定；4）利用脂质体将ZNRD1的真核表达载体及其空载体转染胃癌细胞（AGS、SGC7901、MKN28）和小鼠成纤维细胞（NIH3T3），G418筛选后进行鉴定；5）利用脂质体将ZNRD1的小干扰RNA载体及其空载体转染药敏胃癌细胞（SGC7901）、正常胃组织上皮细胞（GES-1）、对长春新碱耐药的胃癌细胞（SGC7901/VCR）、药敏白血病细胞（HL-60）、对长春新碱耐药的白血病细胞（HL-60/VCR），G418筛选后进行鉴定；6）利用MTT实验检测ZNRD1高/低表达对细胞（AGS、SGC7901、MKN28、NIH3T3、GES-1）生长的影响；7）通过软琼脂克隆形成实验检测上调ZNRD1对AGS、MKN28细胞克隆形成能力的影响；8）通过裸鼠成瘤实验检测上调ZNRD1对AGS、MKN28细胞体内成瘤性的影响；9）通过流式细胞仪分析ZNRD1高/低表达对细胞（AGS、MKN28、NIH3T3、GES-1）的细胞周期的影响；10）通过流式细胞仪分析上调ZNRD1对细胞（AGS、MKN28、NIH3T3）的凋亡的影响；11）通过MTT实验检测ZNRD1高/低表达对细胞（SGC7901、SGC7901/VCR、HL-60、HL-60/VCR）体外药物敏感性的影响；12）通过肾包膜下移植法检测ZNRD1高/低表达对细胞（SGC7901、SGC7901/VCR）体内药物敏感性的影响；13）通过流式细胞仪分析ZNRD1高/低表达对细胞（SGC7901、SGC7901/VCR、HL-60、HL-60/VCR）内阿霉素蓄积和泵出的影响；14）通过透射电镜检测上调ZNRD1对SGC7901细胞凋亡敏感性的影响；15）通过流式细胞仪和DNA梯度试验检测ZNRD1高/低表达对细胞（SGC7901、SGC7901/VCR、HL-60）凋亡敏感性的影响；16）通过基因芯片检测ZNRD1高/低表达对胃癌细胞内基因表达谱的影响；17）利用RT-PCR、Western blot对基因芯片的结果进行鉴定；18）利用报告基因实验检测ZNRD1对cyclin D1的启动子活性的调节作用；19）利用报告基因实验检测ZNRD1高/低表达对MDR1的启动子活性的调节作用；20）利用激酶试验检测ZNRD1对cyclin E-CDK2 激酶活力的影响；21）利用反义核酸技术抑制p21的表达；通过流式细胞仪检测抑制p21对ZNRD1介导的细胞周期阻滞的影响；22）利用反义核酸技术抑制p27的表达；通过流式细胞仪检测抑制p27对ZNRD1介导的细胞周期阻滞的影响；23）利用脂质体转染法上调Skp2的表达；通过流式细胞仪检测上调Skp2对ZNRD1介导的细胞周期阻滞的影响；24）利用Western blot检测ZNRD1对p27和Skp2的蛋白稳定性的影响；25）利用微血管密度实验检测ZNRD1对AGS、MKN28细胞裸鼠移植瘤微血管形成的影响；26）利用ELISA检测ZNRD1对AGS、MKN28细胞培养上清和移植瘤匀浆中VEGF165含量的影响；27）利用脂质体转染法、MTT实验、肾包膜下移植法、流式细胞仪和DNA梯度试验检测新耐药相关分子DARPP-32对细胞（SGC7901、SGC7901/VCR、对阿霉素耐药的胃癌细胞SGC7901/ADR）多药耐药表型的影响；利用脂质体转染法和MTT实验检测下调ZNRD1对DARPP-32介导的胃癌多药耐药的调控作用。

与tar cancer相关的网络解释 [注：此内容来源于网络，仅供参考]

tar cancer：焦油癌

taq polymerase taq 多聚酶 | tar cancer 焦油癌 | tardigrada 缓步类

tar cancer：煤胶癌

Tape-worm disease; Teniasis 绦虫病 | Tar cancer 煤胶癌 | Tar poisoning 煤油焦中毒

tar cancer：煤焦油癌

tar boiler ==> 柏油溶化炉 | tar cancer ==> 煤焦油癌 | tar cement ==> 柏油胶合料

tar cancer：沥青癌

轴根 taproot;axial root | 沥青癌 tar cancer | 大风子树(印度产) Taractogenos kurzii King

coal tar worker's cancer：煤焦油工癌

coal miner's disease 炭硅肺 | coal tar worker's cancer 煤焦油工癌 | coalescence 结合